摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(1R,8S)-1-chloromethyl-2,2-dichloro-3-oxo-hexahydropyrrolizidine | 141521-13-3

中文名称
——
中文别名
——
英文名称
(1R,8S)-1-chloromethyl-2,2-dichloro-3-oxo-hexahydropyrrolizidine
英文别名
(1R,7aS)-1-chloromethyl-2,2-dichloro-hexahydropyrrolizin-3-one;(1R,8S)-2,2-dichloro-1-(chloromethyl)-5,6,7,8-tetrahydro-1H-pyrrolizin-3-one
(1R,8S)-1-chloromethyl-2,2-dichloro-3-oxo-hexahydropyrrolizidine化学式
CAS
141521-13-3
化学式
C8H10Cl3NO
mdl
——
分子量
242.532
InChiKey
NWIZMFGYLMKIGO-WDSKDSINSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.1
  • 重原子数:
    13
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.88
  • 拓扑面积:
    20.3
  • 氢给体数:
    0
  • 氢受体数:
    1

反应信息

  • 作为反应物:
    描述:
    (1R,8S)-1-chloromethyl-2,2-dichloro-3-oxo-hexahydropyrrolizidine 在 palladium on activated charcoal 氢气sodium acetate 、 sodium iodide 作用下, 以 乙醇丁酮 为溶剂, 反应 24.0h, 生成 (1R,8S)-1-iodomethyl-3-oxo-hexahydropyrrolizidine
    参考文献:
    名称:
    Synthesis of pyrrolizidines via copper(I) catalyzed radical atom transfer cyclization
    摘要:
    Trachelanthamidine and pseudoheliotridane are synthesized from 2S)-N-trichlkoroacetyl-2-vinylpyrrolidine (5) by a 5-exo-trig radical cyclization. The intermediate radical is generated heating 5 in a sealed tube (CH3CN/ 160-degrees-C) using CuCl as catalyst and the cyclization occurs in very good yield (93%). Cyclized product 6 is transformed either into (-)-trachelanthamidine (55% yield from 5) or into (-)-pseudoheliotridane (42% yield from 5).
    DOI:
    10.1016/s0040-4020(01)88722-6
  • 作为产物:
    参考文献:
    名称:
    Synthesis of pyrrolizidines via copper(I) catalyzed radical atom transfer cyclization
    摘要:
    Trachelanthamidine and pseudoheliotridane are synthesized from 2S)-N-trichlkoroacetyl-2-vinylpyrrolidine (5) by a 5-exo-trig radical cyclization. The intermediate radical is generated heating 5 in a sealed tube (CH3CN/ 160-degrees-C) using CuCl as catalyst and the cyclization occurs in very good yield (93%). Cyclized product 6 is transformed either into (-)-trachelanthamidine (55% yield from 5) or into (-)-pseudoheliotridane (42% yield from 5).
    DOI:
    10.1016/s0040-4020(01)88722-6
点击查看最新优质反应信息

文献信息

  • Atom-transfer radical reactions catalyzed by a coordinatively unsaturated diruthenium amidinate, [(η5-C5Me5)Ru(μ2-i-PrN C(Me)Ni-Pr)Ru(η5-C5Me5)]+
    作者:Yukihiro Motoyama、Shiori Hanada、Shota Niibayashi、Kazuya Shimamoto、Naoki Takaoka、Hideo Nagashima
    DOI:10.1016/j.tet.2005.08.037
    日期:2005.10
    Atom-transfer radical cyclization (ATRC) and addition (ATRA) catalyzed by a coordinatively unsaturated diruthenium amidinate complex 4, [(η5-C5Me5)Ru(μ2-i-PrNC(Me)Ni-Pr)Ru(η5-C5Me5)]+, are investigated, and their features are compared with those of atom-transfer radical polymerization (ATRP). As an example of ATRC, a cationic diruthenium amidinate 4 is found to exhibit excellent catalytic reactivity
    由配位不饱和二钌催化原子转移自由基环化(ATRC)和加成(ATRA)脒基络合物4,[(η 5 -C 5我5)的Ru(μ 2 -我-PrNC(ME)N我-Pr)的Ru (η 5 -C 5我5)] +,进行了研究,它们的特征与那些原子转移自由基聚合(ATRP)的比较。作为ATRC的一个例子,发现阳离子di胺酸二钌4对N的环化具有极好的催化反应活性。-烯丙基α-卤代乙酰胺,包括环境温度下的生物碱骨架。从卤化物络合物原位产生的催化物种,(η 5 -C 5我5)的Ru(μ 2 -我-PrNC(ME)N我-Pr)的Ru(η 5 -C 5我5)(X)[ X = Cl,Br]和弱配位阴离子如NaPF 6和NaBPh 4的钠盐也显示出高催化活性。这实际上提供了解决作为实用催化剂的不稳定的4的解决方案。原位生成的催化剂种类4在室温下,α-烯烃对α,α,γ-三氯化γ-内酰胺与烯烃的分子间ATRA也有活性,以中等
  • A Cationic Diruthenium Amidinate, [(η<sup>5</sup>-C<sub>5</sub>Me<sub>5</sub>)Ru(μ<sub>2</sub>-<i>i</i>-PrN=C(Me)N<i>i</i>-Pr)Ru(η<sup>5</sup>-C<sub>5</sub>Me<sub>5</sub>)]<sup>+</sup>, as an Efficient Catalyst for the Atom-Transfer Radical Reactions
    作者:Yukihiro Motoyama、Mitsuru Gondo、Satoshi Masuda、Yuya Iwashita、Hideo Nagashima
    DOI:10.1246/cl.2004.442
    日期:2004.4
    A cationic diruthenium amidinate, [(η5-C5Me5)Ru(μ2-i-PrN=C(Me)Ni-Pr)Ru(η5-C5Me5)]+, is generated by treatment of (η5-C5Me5)Ru(μ2-i-PrN=C(Me)Ni-Pr)Ru(Cl)(η5-C5Me5) (3a) with NaPF6 or other metal salts of weakly coordinating anions, which is active towards catalytic atom transfer radical cyclization of N-allyl trichloroacetamides and related reactions.
    通过处理 (η5-C5Me5)Ru(μ2- 生成阳离子二钌脒盐,[(η5-C5Me5)Ru(μ2-i-PrN=C(Me)Ni-Pr)Ru(η5-C5Me5)]+ i-PrN=C(Me)Ni-Pr)Ru(Cl)(η5-C5Me5) (3a) 与 NaPF6 或其他弱配位阴离子的金属盐,对 N-烯丙基三氯乙酰胺的催化原子转移自由基环化具有活性相关反应。
  • Ikeda, Masazumi; Teranishi, Hirotaka; Iwamura, Noriko, Heterocycles, 1997, vol. 45, # 5, p. 863 - 866
    作者:Ikeda, Masazumi、Teranishi, Hirotaka、Iwamura, Noriko、Ishibashi, Hiroyuki
    DOI:——
    日期:——
  • Ngashima, Hideo; Gondo, Mitsuru; Masuda, Satoshi, Chemical Communications, 2003, # 3, p. 442 - 444
    作者:Ngashima, Hideo、Gondo, Mitsuru、Masuda, Satoshi、Kondo, Hideo、Yamaguchi, Yoshitaka、Matsubara, Kouki
    DOI:——
    日期:——
  • Synthesis of pyrrolizidines via copper(I) catalyzed radical atom transfer cyclization
    作者:Julio A. Seijas、M.Pilar Vázquez-Tato、Luis Castedo、Ramón J. Estévez、M.Gabriela Ónega、Maria Ruíz
    DOI:10.1016/s0040-4020(01)88722-6
    日期:1992.2
    Trachelanthamidine and pseudoheliotridane are synthesized from 2S)-N-trichlkoroacetyl-2-vinylpyrrolidine (5) by a 5-exo-trig radical cyclization. The intermediate radical is generated heating 5 in a sealed tube (CH3CN/ 160-degrees-C) using CuCl as catalyst and the cyclization occurs in very good yield (93%). Cyclized product 6 is transformed either into (-)-trachelanthamidine (55% yield from 5) or into (-)-pseudoheliotridane (42% yield from 5).
查看更多

同类化合物

颈花脒 罗拉西坦 矛裂碱 甲基六氢-1H-吡咯里嗪-1-羧酸酯 瓶千里光碱N-氧化物 新瓶草千里光碱 异款冬碱 季普拉嗪 四氢-1H-吡咯里嗪-2(3H)-酮 四氢-1H-吡咯烷-7a(5H)-乙酸 四氢-1H-吡咯并吡咯烷-7a(5H)-乙胺二盐酸盐 四氢-1H-吡咯嗪-7a(5h)-乙酸乙酯 响铃豆碱 去甲一叶秋碱 六氢-吡咯嗪-1-酮 六氢-3-(羟甲基)-1H-吡咯里嗪-1,2,7-三醇 六氢-1H-吡咯里嗪-2-羧酸 六氢-1H-吡咯里嗪 六氢-1H-吡咯嗪-7A-甲腈 倒千里光裂醇 二[[(1R,8R)-2,3,5,6,7,8-六氢-1H-吡咯里嗪-1-基]甲基]2,4-二(4-羟基苯基)环丁烷-1,3-二羧酸酯 [(1S,8R)-2,3,5,6,7,8-六氢-1H-吡咯里嗪-1-基]甲醇 [(1S,7R,8R)-7-[(Z)-2-甲基丁-2-烯酰基]氧基-2,3,5,6,7,8-六氢-1H-吡咯里嗪-1-基]甲基 (Z)-2-(羟基甲基)丁-2-烯酸酯 7a-乙氧基-7,7-二甲基六氢-3H-吡咯里嗪-3-酮 7Alpha-双稠吡咯啶-乙酸盐酸盐 7Alpha-双稠吡咯啶-乙腈 7-甲基六氢-1H-吡咯里嗪-1-酮 7,8-二羟基-4'-甲氧基异黄酮 5-甲氧羰基甲基-1-氮杂双环[3.3.0]辛烷 5-氧代六氢-1H-吡咯里嗪-1-甲醛 5-(2-氨基乙基)-1-氮杂双环[3.3.0]辛烷 2,3,5,6,7,8-六氢-1H-吡咯里嗪-1-胺 1-氮杂二环[2.2.1]庚烷,3-(5-异[口噁]唑基)-,外-(9CI) (六氢-1H-吡咯里嗪-7A-基)甲胺 (Z)-2-甲基-2-丁烯酸[(1S,2R,7aS)-六氢-1-羟基甲基-1H-吡咯里嗪-2-基]酯 (Z)-2-甲基-2-丁烯酸[(1S,2R,7aR)-六氢-2beta-羟基-1H-吡咯里嗪-1beta-基]甲基酯 (7aS)-六氢-3H-吡咯里嗪-3-酮 (7aS)-2-甲基四氢-1H-吡咯里嗪-1,3(2H)-二酮 (7R,7aR)-7-异丙基六氢-3H-吡咯里嗪-3-酮 (2S,3S)-2,3-二羟基-2-异丙基丁酸[(1R,7aalpha)-六氢-1H-吡咯里嗪-1-基]甲基酯 (2S,3R)-2,3-二羟基-2-异丙基丁酸[(1R,7aR)-六氢-1H-吡咯里嗪-1-基]甲基酯 (2S,3R)-2,3-二羟基-2-异丙基丁酸 [(1R,7aS)-2,3,5,6,7,7a-六氢-1H-吡咯里嗪-1-基]甲酯 (1S-(1alpha,2alpha,7aalpha))-六氢-2-羟基-2-甲基-1H-吡咯里嗪-1-羧酸甲酯 (1R,8S)-3-氧代-1,2,5,6,7,8-六氢吡咯里嗪e-1-甲醛 (1R,8S)-1-甲基六氢-1H-吡咯嗪 (1R,8R)-7-亚甲基-1,2,3,5,6,8-六氢吡咯里嗪-1-醇 (1R,7aS)-1-[[[(2S,3R)-2,3-二羟基-2-异丙基丁酰基]氧基]甲基]六氢-1H-吡咯里嗪4-氧化物 (1R,7S,8R)-7-(羟基甲基)-2,3,5,6,7,8-六氢-1H-吡咯里嗪-1-醇 (1R,6S,7S,8R)-7-(羟甲基)-2,3,5,6,7,8-六氢-1H-吡咯嗪-1,6-二醇 (1R,2R,3R,7S,8S)-3-(羟基甲基)-2,3,5,6,7,8-六氢-1H-吡咯里嗪-1,2,7-三醇